PRECLINICAL EFFICACY OF A PROTOTYPE DNA VACCINE - ENHANCED PROTECTION AGAINST ANTIGENIC DRIFT IN INFLUENZA-VIRUS

被引：265

作者：

DONNELLY, JJ

FRIEDMAN, A

MARTINEZ, D

MONTGOMERY, DL

SHIVER, JW

MOTZEL, SL

ULMER, JB

LIU, MA

机构：

[1] MERCK SHARP & DOHME LTD, DEPT VIRUS & CELL BIOL, RES LABS, West Point, PA 19486 USA

[2] MERCK SHARP & DOHME LTD, DEPT LAB ANIM RESOURCES, RES LABS, West Point, PA 19486 USA

来源：

NATURE MEDICINE | 1995年 / 1卷 / 06期

关键词：

D O I：

10.1038/nm0695-583

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Vaccination with plasmid DNA expression vectors encoding foreign proteins elicits antibodies and cell-mediated immunity and protects against disease in animal models. We report a comparison of DNA vaccines, using contemporary human strains of virus, and clinically licensed (inactivated virus or subvirion) vaccines in preclinical animal models, to better predict their efficacy in humans. Influenza DNA vaccines elicited antibodies in both non-human primates and ferrets and protected ferrets against challenge with an antigenically distinct epidemic human influenza virus more effectively than the contemporary clinically licensed vaccine. These studies demonstrate that DNA vaccines may be more effective, particularly against different strains of virus, than inactivated virus or subvirion vaccines.

引用

页码：583 / 587

页数：5

共 37 条

[21]

Wolff J.A., Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle, Hum. Molec. Genet, 1, pp. 363-369, (1992)

[22]

Manthorpe M., Et al., Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice, Hum. Gene Ther, 4, pp. 419-431, (1993)

[23]

Clements M.L., Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza BJAnn ArborJ1J86 reassortant virus vaccine in adult volunteers, J. Infect. Dis, 161, pp. 869-877, (1990)

[24]

Powers D.C., Elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory, J. Din. Microbiol, 29, pp. 498-505, (1991)

[25]

Ulmer J.B., Et al., Heterologous protective immunity to influenza A by intramuscular injection of DNA encoding a conserved viral protein, Science, 259, pp. 1745-1749, (1993)

[26]

Montgomery D.L., Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of DNA vectors, DNA Cell Biol, 12, pp. 777-784, (1993)

[27]

Wang B., Gene inoculation generates immune responses against human immunodeficiency virus type 1, Proc. Natn. Acad. Sci. U.S.A., 90, pp. 4156-4160, (1993)

[28]

Cox T.J., Babiuk L.A., Bovine Herpesvirus 1: Immune responses in mice and cattle injected with plasmid DNA, J. Virol, 67, pp. 5664-5667, (1993)

[29]

Xiang Z.Q., Vaccination with a plasmid carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus, Virology, 199, pp. 132-140, (1994)

[30]

Both G.W., Sleigh M.J., Cox N.J., Kendal A.P., Antigenic drift in influenza virus H3 haemagglutinin from 1968 to 1980: Multiple evolutionary pathways and sequential amino acid changes at key antigenic sites, J. Virol, 48, pp. 52-60, (1983)

← 1 2 3 4 →